SCHEMBL2213865

SCHEMBL2213865

C[C@@H]1CN(c2ncc(-c3nccs3)cc2C=O)C[C@H](C)O1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.35
MAPT P10636 2/20 0.35
HTT P42858 2/20 0.35
HPGD P15428 1/20 0.35
GAK O14976 4/20 0.34
GAA P10253 2/20 0.34
RAB9A P51151 1/20 0.34
KDM4E B2RXH2 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
LMNA P02545 1/20 0.33
ATM Q13315 1/20 0.33
PIK3CA P42336 4/20 0.32
PIK3CD O00329 3/20 0.32
PIK3CB P42338 2/20 0.32
AOC3 Q16853 2/20 0.32
PIK3CG P48736 2/20 0.32
CHEK2 O96017 1/20 0.32
PIK3R1 P27986 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2213457 0.83 ALDH1A1 (0.34) ALDH1A1MAPTHTTHPGDGAK
SCHEMBL2216394 0.82 CYP2A6 (0.43) ALDH1A1MAPTHTTHPGDGAK
SCHEMBL2247014 0.81 PIK3CA (0.40) ALDH1A1MAPTHTTGAKGAA
SCHEMBL2247007 0.81 PIK3CA (0.40) ALDH1A1MAPTHTTGAKGAA
SCHEMBL2213140 0.81 GAA (0.42) ALDH1A1MAPTHPGDGAKGAA
SCHEMBL2216534 0.81 GSK3B (0.36) ALDH1A1MAPTGAKGAARAB9A
SCHEMBL2216042 0.80 GAK (0.41) ALDH1A1MAPTGAKGAARAB9A
SCHEMBL2215017 0.80 GAK (0.35) ALDH1A1MAPTGAKGAARAB9A
SCHEMBL2215416 0.79 GAK (0.52) ALDH1A1MAPTHTTHPGDGAK
SCHEMBL2215363 0.79 LRRK2 (0.40) ALDH1A1MAPTGAKGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110178064-A1 SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL ASTRAZENECA R&D (SE) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178064-A1 SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL TBCA, TUBA1A, BROX ALDH1A1 246/4885MAPT 2817/4885HTT 3702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.